Insiders · SNTI

SNTI insider transactions

Senti Biosciences Inc. (SNTI) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for SNTI

• 89d
  Pres. & Chief Med. & Dev. Off. Rajangam Kanya covered exercise/tax liability with 10,757 shares (SEC Form 4)

  4 - Senti Biosciences, Inc. (0001854270) (Issuer)
• 89d
  CEO Lu Timothy K covered exercise/tax liability with 80,666 shares (SEC Form 4)

  4 - Senti Biosciences, Inc. (0001854270) (Issuer)
• 125d
  Pres. & Chief Med. & Dev. Off. Rajangam Kanya covered exercise/tax liability with 1,384 shares (SEC Form 4)

  4 - Senti Biosciences, Inc. (0001854270) (Issuer)
• 125d
  CEO Lu Timothy K covered exercise/tax liability with 4,191 shares, decreasing direct ownership by 0.58% to 720,249 units (SEC Form 4)

  4 - Senti Biosciences, Inc. (0001854270) (Issuer)
• 322d
  SEC Form 4 filed by Director Baum Bryan Daniel

  4 - Senti Biosciences, Inc. (0001854270) (Issuer)
• 322d
  SEC Form 3 filed by new insider Baum Bryan Daniel

  3 - Senti Biosciences, Inc. (0001854270) (Issuer)
• 346d
  SEC Form 4 filed by Director Collins James J.

  4 - Senti Biosciences, Inc. (0001854270) (Issuer)
• 346d
  SEC Form 4 filed by Director Hsiung Feng

  4 - Senti Biosciences, Inc. (0001854270) (Issuer)
• 346d
  SEC Form 4 filed by Director Schulz Fran

  4 - Senti Biosciences, Inc. (0001854270) (Issuer)
• 346d
  SEC Form 4 filed by Director Cooperstone Brenda

  4 - Senti Biosciences, Inc. (0001854270) (Issuer)
• 346d
  SEC Form 4 filed by Director Tang Donald F

  4 - Senti Biosciences, Inc. (0001854270) (Issuer)
• 346d
  SEC Form 4 filed by Director Mathers Edward T

  4 - Senti Biosciences, Inc. (0001854270) (Issuer)
• 451d
  Large owner Celadon Partners Spv 24 converted options into 9,777,000 shares (SEC Form 4)

  4 - Senti Biosciences, Inc. (0001854270) (Issuer)
• 452d
  SEC Form 3 filed by new insider Celadon Partners Spv 24

  3 - Senti Biosciences, Inc. (0001854270) (Issuer)
• 453d
  Large owner New Enterprise Associates 15, L.P. converted options into 3,333,000 shares (SEC Form 4)

  4 - Senti Biosciences, Inc. (0001854270) (Issuer)
• 453d
  New insider New Enterprise Associates 15, L.P. claimed ownership of 442,615 shares (SEC Form 3)

  3 - Senti Biosciences, Inc. (0001854270) (Issuer)
• 453d
  Large owner Bayer Healthcare Llc converted options into 2,222,000 shares (SEC Form 4)

  4 - Senti Biosciences, Inc. (0001854270) (Issuer)
• 454d
  SEC Form 4 filed by Director Mathers Edward T

  4 - Senti Biosciences, Inc. (0001854270) (Issuer)
• 454d
  Pres. & Chief Med. & Dev. Off. Rajangam Kanya converted options into 33,000 shares (SEC Form 4)

  4 - Senti Biosciences, Inc. (0001854270) (Issuer)
• 454d
  SEC Form 4 filed by Director Schulz Fran

  4 - Senti Biosciences, Inc. (0001854270) (Issuer)
• 454d
  SEC Form 4 filed by Director Collins James J.

  4 - Senti Biosciences, Inc. (0001854270) (Issuer)
• 454d
  SEC Form 4 filed by Director Tang Donald F

  4 - Senti Biosciences, Inc. (0001854270) (Issuer)
• 454d
  SEC Form 4 filed by Director Cooperstone Brenda

  4 - Senti Biosciences, Inc. (0001854270) (Issuer)
• 454d
  SEC Form 4 filed by Director Hsiung Feng

  4 - Senti Biosciences, Inc. (0001854270) (Issuer)
• 454d
  SEC Form 3 filed by new insider Hsiung Feng

  3 - Senti Biosciences, Inc. (0001854270) (Issuer)
• 454d
  SEC Form 4 filed by Chief Financial Officer Cross John Harry Iii

  4 - Senti Biosciences, Inc. (0001854270) (Issuer)
• 454d
  SEC Form 3 filed by new insider Cross John Harry Iii

  3 - Senti Biosciences, Inc. (0001854270) (Issuer)
• 455d
  Pres. & Chief Med. & Dev. Off. Rajangam Kanya was granted 78,363 shares, increasing direct ownership by 909% to 86,984 units (SEC Form 4)

  4 - Senti Biosciences, Inc. (0001854270) (Issuer)
• 455d
  CEO and Interim PFO and PAO Lu Timothy K was granted 642,358 shares, increasing direct ownership by 783% to 724,440 units (SEC Form 4)

  4 - Senti Biosciences, Inc. (0001854270) (Issuer)
• 487d
  CEO Lu Timothy K sold $18,339 worth of shares (4,467 units at $4.11), decreasing direct ownership by 5% to 82,082 units (SEC Form 4)

  4 - Senti Biosciences, Inc. (0001854270) (Issuer)
• 487d
  Pres. & Chief Med. & Dev. Off. Rajangam Kanya sold $6,074 worth of shares (1,479 units at $4.11), decreasing direct ownership by 15% to 8,621 units (SEC Form 4)

  4 - Senti Biosciences, Inc. (0001854270) (Issuer)
• 544d
  SEC Form 4 filed by Large owner Bayer Healthcare Llc

  4 - Senti Biosciences, Inc. (0001854270) (Issuer)
• 545d
  SEC Form 4 filed by Director Tang Donald F

  4 - Senti Biosciences, Inc. (0001854270) (Issuer)
• 545d
  New insider Tang Donald F claimed ownership of 10,368 shares (SEC Form 3)

  3 - Senti Biosciences, Inc. (0001854270) (Issuer)
• 545d
  SEC Form 4 filed by Director Schulz Fran

  4 - Senti Biosciences, Inc. (0001854270) (Issuer)
• 545d
  SEC Form 3 filed by new insider Schulz Fran

  3 - Senti Biosciences, Inc. (0001854270) (Issuer)
• 545d
  SEC Form 4 filed by Pres. & Chief Med. & Dev. Off. Rajangam Kanya

  4 - Senti Biosciences, Inc. (0001854270) (Issuer)
• 696d
  SEC Form 4 filed by Director Mathers Edward T

  4 - Senti Biosciences, Inc. (0001854270) (Issuer)
• 696d
  SEC Form 4 filed by Director Farokhzad Omid

  4 - Senti Biosciences, Inc. (0001854270) (Issuer)
• 696d
  SEC Form 4 filed by Director Collins James J.

  4 - Senti Biosciences, Inc. (0001854270) (Issuer)
• 696d
  SEC Form 4 filed by Director Cooperstone Brenda

  4 - Senti Biosciences, Inc. (0001854270) (Issuer)
• 760d
  SEC Form 3 filed by new insider Li Yvonne

  3 - Senti Biosciences, Inc. (0001854270) (Issuer)
• 857d
  Rajangam Kanya was granted 101,000 shares (SEC Form 4)

  4 - Senti Biosciences, Inc. (0001854270) (Issuer)
• 857d
  Lu Timothy K was granted 306,000 shares, increasing direct ownership by 55% to 865,496 units (SEC Form 4)

  4 - Senti Biosciences, Inc. (0001854270) (Issuer)
• 857d
  Knobelman Deborah was granted 101,000 shares, increasing direct ownership by 337% to 131,000 units (SEC Form 4)

  4 - Senti Biosciences, Inc. (0001854270) (Issuer)
• 1083d
  SEC Form 4 filed by Mathers Edward T

  4 - Senti Biosciences, Inc. (0001854270) (Issuer)
• 1083d
  SEC Form 4 filed by Berland Susan D

  4 - Senti Biosciences, Inc. (0001854270) (Issuer)
• 1083d
  SEC Form 4 filed by Collins James J.

  4 - Senti Biosciences, Inc. (0001854270) (Issuer)
• 1083d
  SEC Form 4 filed by Cooperstone Brenda

  4 - Senti Biosciences, Inc. (0001854270) (Issuer)
• 1083d
  SEC Form 4 filed by Farokhzad Omid

  4 - Senti Biosciences, Inc. (0001854270) (Issuer)
• 1211d
  SEC Form 3: New insider Bayer Healthcare Llc claimed ownership of 5,878,488 shares

  3 - Senti Biosciences, Inc. (0001854270) (Issuer)
• 1222d
  SEC Form 4 filed by Lee Philip J

  4 - Senti Biosciences, Inc. (0001854270) (Issuer)
• 1222d
  SEC Form 4 filed by Rajangam Kanya

  4 - Senti Biosciences, Inc. (0001854270) (Issuer)
• 1222d
  SEC Form 4 filed by Knobelman Deborah

  4 - Senti Biosciences, Inc. (0001854270) (Issuer)
• 1222d
  SEC Form 4 filed by Lu Timothy K

  4 - Senti Biosciences, Inc. (0001854270) (Issuer)